iBio, Inc (IBIO) insider trading

Every open-market stock purchase and sale by iBio, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Marc Banjak (C-suite exec), $20.5K, 6 months ago.

Last 12 months: insiders bought $98.1K (3 buys) and sold $0 (0 sales). Last close $1.82 on Jun 4, 2026.

Recent IBIO insider trades

DateInsiderTradeValue
May 18, 2026Elizabeth Stoner (Director)Bought (not open market)—
Mar 26, 2026Marc Banjak (C-suite exec)Bought$20.5K
Mar 26, 2026Marc Banjak (C-suite exec)Bought$2.5K
Mar 19, 2026Felipe Duran (CFO)Bought$50.1K
Mar 19, 2026Martin Brenner (Officer)Bought$24.9K
Jan 28, 2026Martin Brenner (Officer)Bought (not open market)—
Jan 28, 2026Marc Banjak (C-suite exec)Bought (not open market)—
Jan 28, 2026Felipe Duran (CFO)Bought (not open market)—
Nov 20, 2025Alexandra Kropotova (Director)Bought (not open market)—
Nov 20, 2025Gary Sender (Director)Bought (not open market)—
Nov 20, 2025Antonio Bernardino Guimaraes Parada (Director)Bought (not open market)—
Nov 20, 2025David Arkowitz (Director)Bought (not open market)—
Nov 20, 2025William D Clark (Director)Bought (not open market)—
Nov 20, 2025Evert B. Schimmelpennink (Director)Bought (not open market)—
Oct 20, 2025Marc Banjak (C-suite exec)Bought (not open market)—
Oct 20, 2025Felipe Duran (CFO)Bought (not open market)—
Oct 20, 2025Martin Brenner (Officer)Bought (not open market)—

Who's trading IBIO

Get free alerts when an insider at iBio, Inc files a new trade →